- Home
- STRO vs ADTN Comparison
STRO vs ADTN Comparison
Compare STRO & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- ADTN
- Stock Information
- Founded
- STRO 2003
- ADTN 1985
- Country
- STRO United States
- ADTN United States
- Employees
- STRO N/A
- ADTN N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- ADTN Telecommunications Equipment
- Sector
- STRO Health Care
- ADTN Telecommunications
- Exchange
- STRO Nasdaq
- ADTN Nasdaq
- Market Cap
- STRO 172.8M
- ADTN 656.7M
- IPO Year
- STRO 2018
- ADTN 1994
- Fundamental
- Price
- STRO $1.72
- ADTN $9.94
- Analyst Decision
- STRO Strong Buy
- ADTN Strong Buy
- Analyst Count
- STRO 7
- ADTN 4
- Target Price
- STRO $12.14
- ADTN $11.50
- AVG Volume (30 Days)
- STRO 1.1M
- ADTN 788.2K
- Earning Date
- STRO 11-13-2024
- ADTN 02-24-2025
- Dividend Yield
- STRO N/A
- ADTN N/A
- EPS Growth
- STRO N/A
- ADTN N/A
- EPS
- STRO N/A
- ADTN N/A
- Revenue
- STRO $160,955,000.00
- ADTN $905,347,000.00
- Revenue This Year
- STRO N/A
- ADTN N/A
- Revenue Next Year
- STRO N/A
- ADTN $10.32
- P/E Ratio
- STRO N/A
- ADTN N/A
- Revenue Growth
- STRO 230.90
- ADTN N/A
- 52 Week Low
- STRO $1.67
- ADTN $4.34
- 52 Week High
- STRO $6.13
- ADTN $10.71
- Technical
- Relative Strength Index (RSI)
- STRO 29.77
- ADTN 66.62
- Support Level
- STRO $1.80
- ADTN $9.59
- Resistance Level
- STRO $2.15
- ADTN $10.71
- Average True Range (ATR)
- STRO 0.13
- ADTN 0.41
- MACD
- STRO 0.03
- ADTN 0.13
- Stochastic Oscillator
- STRO 10.42
- ADTN 70.38
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.